课题基金 / 基金详情

Mechanisms of cell death and autophagy in intestinal epithelial cells in inflammation and cancer

Mechanisms of cell death and autophagy in intestinal epithelial cells in inflammation and cancer
炎症和癌症中肠上皮细胞的细胞死亡和自噬机制
批准号:
10180908
负责人:
Jorge Moscat
金额:
$38.77万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-21 至 2022-02-28

项目摘要

项目成果

Jorge Moscat的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 肠上皮细胞(IECs)起着屏障和细胞工厂的作用 并加工膳食营养素,以及分泌防御分子和协调免疫 回应。IECS正常功能的改变与炎症性肠病等病理改变有关 (IBD)。重要的是,IBD患者患结直肠癌(CRC)的风险增加,这是 美国人口中最常见的肿瘤。最近的研究表明潘氏细胞的关键作用 控制肠内皮细胞存活和肠炎发病机制的功能障碍。因此, 了解不同的信号级联如何控制肠道内稳态是一个基本的问题。 对IBD和CRC具有潜在治疗意义的生物学。我们将在上下文中解决这些问题 PKcλ/ι.我们的初步数据表明,在IECS中,PKCλ/ι的选择性失活导致了这种损失 潘氏细胞,引起肠道屏障的破坏,生物失调,肠道炎症和 肿瘤形成增加。重要的是,蛋白激酶Cλ/ι的表达随着CD的进展而减少,它预示着CD的不良发展 结直肠癌的存活率。值得注意的是,这种潘氏细胞缺陷与隐窝细胞凋亡、JNK活性和 PKCλ/ι缺陷IECs中的自噬。我们的假设是PKCλ/ι是自噬的重要调节因子,并且 肠道细胞动态平衡和炎症驱动的肿瘤发生中的细胞死亡。在这份提案中,我们将解决 下列基本问题:(1)pkcλ/ι缺乏在体内激活jnk的作用是什么? 肠内皮细胞凋亡增加与肠道炎症和肿瘤的发生?(2)机制是什么 Pkcλ/ι抑制jnk活性的机制?(3)pkcλ/ι缺陷的IECs存活期自噬增强 拮抗PKCλ/ι缺失促进JNK值升高和细胞凋亡的体内机制 预防肠道炎症和肿瘤发生?(4)PKCλ/ι抑制的机制是什么? 自噬?问题1和2将通过目标1中描述的实验来回答;问题3和4将通过目标1中描述的实验回答 将通过目标2中描述的实验来回答。这一提议将揭示一种新的范式, 蛋白激酶Cλ/ι调控内皮细胞凋亡和自噬及其在肠道内稳态和炎症驱动中的作用 肿瘤发生,为新的治疗方法打开了可能性。
英文摘要
SUMMARY Intestinal epithelial cells (IECs) play an important role as barrier and as cellular factories in charge of absorbing and processing dietary nutrients, as well as the secretion of defense molecules and the orchestration of immune responses. Alterations in the normal function of IECs contribute to pathologies like inflammatory bowel diseases (IBD). Importantly, patients with IBD are at an increased risk for colorectal cancer (CRC), which is one of the most prevalent neoplasias among the US population. Recent studies have shown the critical role of Paneth cell dysfunction in controlling IEC survival and the etiopathogeneis of intestinal inflammation. Therefore, understanding how different signaling cascades control intestinal homeostasis is a fundamental question in biology with potential therapeutic implications for IBD and CRC. We will address these questions in the context of PKCλ/ι. Our preliminary data demonstrate that the selective inactivation of PKCλ/ι in IECs results in the loss of Paneth cells, which provokes the break of the intestinal barrier, dysbiosis, intestinal inflammation and increased tumorigenesis. Importantly, PKCλ/ι expression decreases with progression in CD and it predicts poor survival in CRC. Of note, this Paneth cell defect is associated with increased crypt apoptosis, JNK activity and autophagy in PKCλ/ι-deficient IECs. Our hypothesis is that PKCλ/ι is an essential regulator of autophagy and cell death in intestinal cell homeostasis and inflammation-driven tumorigenesis. In this proposal we will address the following fundamental questions: (1) What is the role in vivo of JNK activation by PKCλ/ι deficiency in increased apoptosis of IECs and intestinal inflammation and tumorigenesis? (2) What are the mechanisms whereby PKCλ/ι inhibits JNK activity? (3) Is enhanced autophagy in PKCλ/ι-deficient IECs a survival mechanism in vivo to antagonize the increased JNK and apoptosis promoted by the loss of PKCλ/ι and to prevent intestinal inflammation and tumorigenesis? (4) What are the mechanisms whereby PKCλ/ι represses autophagy? Questions 1 and 2 will be answered by the experiments described in Aim 1; and questions 3 and 4 will be answered by the experiments described in Aim 2. This proposal will unveil a new paradigm whereby PKCλ/ι controls IEC apoptosis and autophagy and their role in intestinal homeostasis and inflammation-driven tumorigenesis, opening possibilities for new therapies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Cholesterol metabolism in mesenchymal colorectal cancer
Molecular mechanisms driving mesenchymal colorectal cancer
Molecular mechanisms driving mesenchymal colorectal cancer
Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
海外基金